NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/life-extending-bile-duct-cancer-drug-cleared-nhs-use-2026a1000cj3?src=rss
Author :
Publish date : 2026-04-21 15:55:00
Copyright for syndicated content belongs to the linked Source.